About the course
Tuberculosis is the leading infectious disease killer and the ninth cause of death globally, affecting close to 11 million people a year with 1.4 million deaths. Multidrug-resistant TB affects half a million people annually and is a growing threat to public health and a significant obstacle to the elimination of this scourge to humanity.
This new programme will provide a comprehensive overview of Tuberculosis with an emphasis on prevention, diagnosis, and management of drug-susceptible Tuberculosis. The programme has been developed for trainees and consultants in infection specialities and respiratory medicine; it can also be taken by TB nurses and public health workers, and practitioners with experience in Tuberculosis.
The programme is delivered via distance learning, allowing students to study at their own pace and in their own time. It will provide an excellent structured learning platform for trainees and specialists to develop their skills in this area. Leading experts deliver lectures in the field, with the same lecturer offering tutorials one-week post release of the talk.
Queen Mary University of London and Barts Health have an excellent reputation in Medicine and Tuberculosis (TB), with active research and teaching programmes in each. Barts Health NHS Trust caters for a large part of East London and treats the largest number of Tuberculosis patients in Western and Central Europe, seeing 10% of national TB cases.